...
首页> 外文期刊>Gene therapy >Ultrasound-targeted microbubble destruction enhances naked plasmid DNA transfection in rabbit Achilles tendons in vivo
【24h】

Ultrasound-targeted microbubble destruction enhances naked plasmid DNA transfection in rabbit Achilles tendons in vivo

机译:超声靶向微泡破坏增强了兔跟腱的裸质粒DNA转染

获取原文
获取原文并翻译 | 示例
           

摘要

The study was to investigate the probability of increasing the transfection of the gene in tendons by ultrasound-targeted microbubble destruction (UTMD), and to search for the most suitable transfection conditions. A mixture of microbubbles and enhanced green fluorescent protein (EGFP) plasmids was injected into rabbit Achilles tendons by different administration routes and the tendons were ultrasound pulse by different ultrasonic conditions in order to determine the most appropriate conditions. Then, the rabbits were divided into four groups: (1) ultrasound + microbubbles + plasmid; (2) ultrasound + plasmid; (3) microbubble + plasmid; (4) plasmid only. EGFP expression in the tendons and other tissues, and the damage to tendon and paratenon were all observed. The results showed that EGFP expression in the tendon was higher by ultrasound pulse with 2W cm 2 of output intensity and a 20% duty cycle for 10 min. Local injection was determined to be the better administration route. Among the four groups, EGFP expression in Group 1 was higher than that in other groups. EGFP expression was highest on seventh day, then it gradually decrease over time, and lasted more than 56 days. EGFP expression was not found in other tissues. There was no obvious injury caused by UTMD. Under suitable conditions, it is feasible to use UTMD as a safe and effective gene transfection therapy for tendon injuries.
机译:该研究旨在研究通过超声靶向微泡破坏(UTMD)增加肌腱中基因转染的可能性,并寻找最合适的转染条件。通过不同的给药途径将微泡和增强型绿色荧光蛋白(EGFP)质粒的混合物注入兔跟腱,并通过不同的超声条件对肌腱进行超声脉冲以确定最合适的条件。然后,将兔子分为四组:(1)超声+微泡+质粒; (2)超声+质粒; (3)微泡+质粒; (4)仅质粒。观察到EGFP在肌腱和其他组织中的表达,以及对肌腱和副腱的损伤。结果表明,超声脉冲在肌腱中的EGFP表达更高,输出强度为2W cm 2,占空比为20%,持续10分钟。确定局部注射是更好的给药途径。在四组中,第一组的EGFP表达高于其他组。 EGFP的表达在第7天最高,然后随时间逐渐下降,持续超过56天。在其他组织中未发现EGFP表达。没有明显的由UTMD引起的伤害。在合适的条件下,将UTMD用作腱损伤的安全有效的基因转染疗法是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号